Boehringer Ingelheim launches “In Reach Africa” Initiative

Boehringer Ingelheim has announced the launch of the ‘Reach in Africa’ program, an initiative that is aimed at facilitating quality and innovative human and animal healthcare access throughout Africa.
The program is set to add more value to the overall health systems across Kenya, Nigeria, Ghana Ethiopia, Uganda, Mozambique, Tanzania, Zambia, Zimbabwe, and Rwanda. It also aims to give access to care, support, and raise awareness around key disease areas and prevention mechanisms.
‘Reach In Africa has a vision of providing accessible medication and healthcare solutions as well as driving innovation and sustainability in Africa” said head of Corporate Division Prescription Medicine at Boehringer Yew, Looi LLiew. “Working with and supporting families, increasing their awareness of key disease and enriching knowledge through education, will add more value and help to prevent diseases from getting worse. “